Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 143

1.

Symbiotic relationship of pharmacogenetics and drugs of abuse.

Rutter JL.

AAPS J. 2006 Mar 24;8(1):E174-84. Review.

2.

Pharmacogenetics of osteoporosis: future perspectives.

Marini F, Brandi ML.

Calcif Tissue Int. 2009 May;84(5):337-47. doi: 10.1007/s00223-009-9226-x. Epub 2009 Mar 7. Review.

PMID:
19271099
3.

The use of pharmacogenetic techniques in drug abuse research.

Marley RJ, Elmer GI, Goldberg SR.

Pharmacol Ther. 1992;53(2):217-37. Review.

PMID:
1641407
4.

[Pharmacogenomics: the quest for individualized therapy].

López-López M, Guerrero-Camacho JL, Familiar-López IM, Jung-Cook H, Corona-Vázquez T, Alonso-Vilatela ME.

Rev Neurol. 2004 Dec 1-15;39(11):1063-71. Review. Spanish.

5.

Genetic sequence data for pharmacogenomics.

Altman RB.

Curr Opin Drug Discov Devel. 2003 May;6(3):297-303. Review.

PMID:
12833660
6.

Pharmacogenetics, pharmacogenomics, and cardiovascular therapeutics: the way forward.

Terra SG, Johnson JA.

Am J Cardiovasc Drugs. 2002;2(5):287-96. Review.

PMID:
14727958
7.

Pharmacogenomics: historical perspective and current status.

Charlab R, Zhang L.

Methods Mol Biol. 2013;1015:3-22. doi: 10.1007/978-1-62703-435-7_1.

PMID:
23824846
8.

Drug target pharmacogenomics: an overview.

Johnson JA.

Am J Pharmacogenomics. 2001;1(4):271-81. Review.

PMID:
12083959
9.

Human inter-individual DNA sequence variation in candidate genes, drug targets, the importance of haplotypes and pharmacogenomics.

Hoehe MR, Timmermann B, Lehrach H.

Curr Pharm Biotechnol. 2003 Dec;4(6):351-78. Review.

PMID:
14683431
10.

The pharmacogenetics of antiplatelet drugs.

Marín F, Roldán V, González-Conejero R, Corral J.

Curr Opin Investig Drugs. 2007 Mar;8(3):213-8. Review.

PMID:
17408116
11.
12.

[Pharmacogenetics: towards personalized medicine].

Gurwitz D, Rehavi M.

Harefuah. 2005 Oct;144(10):711-6, 750. Review. Hebrew.

PMID:
16281764
13.

Pharmacogenetics and the concept of individualized medicine.

Shastry BS.

Pharmacogenomics J. 2006 Jan-Feb;6(1):16-21. Review.

PMID:
16302022
14.

[Implications of pharmacogenetics in every-day practice].

Gerloff T, Roots I.

Internist (Berl). 2005 Nov;46(11):1270-7. Review. German.

PMID:
16170512
15.

Complex disease-associated pharmacogenetics: drug efficacy, drug safety, and confirmation of a pathogenetic hypothesis (Alzheimer's disease).

Roses AD, Saunders AM, Huang Y, Strum J, Weisgraber KH, Mahley RW.

Pharmacogenomics J. 2007 Feb;7(1):10-28. Epub 2006 Jun 13. Review.

PMID:
16770341
16.

Pharmacogenetics: a tool for identifying genetic factors in drug dependence and response to treatment.

Mroziewicz M, Tyndale RF.

Addict Sci Clin Pract. 2010 Dec;5(2):17-29. Review.

17.

Cardiovascular pharmacogenomics.

Johnson JA, Cavallari LH.

Exp Physiol. 2005 May;90(3):283-9. Epub 2005 Mar 18. Review.

18.

Human genetic variation and personalized medicine.

Agrawal S, Khan F.

Indian J Physiol Pharmacol. 2007 Jan-Mar;51(1):7-28. Review.

PMID:
17877289
19.

Pharmacogenomics in cardiovascular disease: the role of single nucleotide polymorphisms in improving drug therapy.

Mango R, Vecchione L, Raso B, Borgiani P, Brunetti E, Mehta JL, Lauro R, Romeo F, Novelli G.

Expert Opin Pharmacother. 2005 Dec;6(15):2565-76. Review.

PMID:
16316297
20.

[From pharmacogenetics to pharmacogenomics: the start of a new era of personalized medicine in nephrology].

Zaza G, Granata S, Mangino M, Grandaliano G, Schena FP.

G Ital Nefrol. 2010 Jul-Aug;27(4):353-66. Review. Italian.

PMID:
20672232
Items per page

Supplemental Content

Write to the Help Desk